Applied Biosystems Stockholders Approve Merger With Invitrogen

NORWALK, Conn.--(BUSINESS WIRE)--Applied Biosystems Inc. (NYSE:ABI) today announced that its stockholders have voted to approve the company's proposed merger with Invitrogen Corporation (NASDAQ:IVGN) at a special meeting of stockholders held today.

"We are pleased with the overwhelming support of this transaction by our stockholders," said Tony L. White, Chairman and Chief Executive Officer of Applied Biosystems. "The combination with Invitrogen presents exciting opportunities for stockholders, customers, and employees alike. The life sciences are one of the most dynamic industries in the global economy, and the merger of these two fine companies should help accelerate medical research, drug development, and the adoption of molecular technologies in other fields such as food and environmental testing."

More than 98 percent of the shares voted were cast in favor of the transaction at the special meeting. The number of shares voted in favor of the transaction represented more than 80 percent of the total shares outstanding and entitled to vote at the meeting.

The closing of the merger is conditioned on receipt of antitrust clearance under the European Council Merger Regulation and other customary closing conditions.

Later today Invitrogen plans to announce the outcome of its special stockholder meeting to consider the merger.

About Applied Biosystems Inc.
Applied Biosystems Inc. (formerly known as Applera Corporation) is a global leader in the development and marketing of instrument-based systems, consumables, software, and services for academic research, the life science industry and commercial markets. Driven by its employees' belief in the power of science to improve the human condition, the company commercializes innovative technology solutions for DNA, RNA, protein and small molecule analysis. Customers across the disciplines of academic and clinical research, pharmaceutical research and manufacturing, forensic DNA analysis, and agricultural biotechnology use the company's tools and services to accelerate scientific discovery, improve processes related to drug discovery and development, detect potentially pathogenic microorganisms, and identify individuals based on DNA sources. Applied Biosystems has a comprehensive service and field applications support team for a global installed base of high-performance genetic and protein analysis solutions. Applied Biosystems Inc. is headquartered in Norwalk, CT. On June 12, 2008, Applera Corporation and Invitrogen Corporation (NASDAQ: IVGN) announced that their Boards of Directors had approved a definitive merger agreement under which Invitrogen will acquire all of the outstanding shares of Applied Biosystems stock. The merger is subject to customary closing conditions. Information about Applied Biosystems, including reports and other information filed by the company with the Securities and Exchange Commission, is available at http://www.appliedbiosystems.com. All information in this release is as of the date of the release, and Applied Biosystems does not undertake any duty to update this information unless required by law.

Copyright 2008 Business Wire All Rights Reserved.